GB201309085D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201309085D0
GB201309085D0 GBGB1309085.7A GB201309085A GB201309085D0 GB 201309085 D0 GB201309085 D0 GB 201309085D0 GB 201309085 A GB201309085 A GB 201309085A GB 201309085 D0 GB201309085 D0 GB 201309085D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1309085.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharna PLC
Original Assignee
Redx Pharna PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharna PLC filed Critical Redx Pharna PLC
Priority to GBGB1309085.7A priority Critical patent/GB201309085D0/en
Publication of GB201309085D0 publication Critical patent/GB201309085D0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
GBGB1309085.7A 2013-05-20 2013-05-20 Compounds Ceased GB201309085D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1309085.7A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1309085.7A GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds
PCT/GB2014/051542 WO2014188173A1 (en) 2013-05-20 2014-05-20 Pyrazolopyrimidine derivatives useful as inhibitors of bruton's tyrosine kinase

Publications (1)

Publication Number Publication Date
GB201309085D0 true GB201309085D0 (en) 2013-07-03

Family

ID=48747060

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1309085.7A Ceased GB201309085D0 (en) 2013-05-20 2013-05-20 Compounds

Country Status (2)

Country Link
GB (1) GB201309085D0 (en)
WO (1) WO2014188173A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410430D0 (en) 2014-06-11 2014-07-23 Redx Pharma Ltd Compounds
RU2712440C2 (en) * 2015-02-12 2020-01-29 Шанхай Дьюд Медикал Сайенс Энд Текнолоджи Ко., Лтд Method of ibrutinib producing
CN106146511A (en) * 2015-04-03 2016-11-23 安润医药科技（苏州）有限公司 Pyrazolopyrimidine derivative, preparation method, pharmaceutical composition and purposes
WO2016154998A1 (en) * 2015-04-03 2016-10-06 安润医药科技（苏州）有限公司 Pyrazolopyrimidine derivative, manufacturing method, pharmaceutical composition, and use thereof
CN104844609B (en) * 2015-05-12 2016-07-13 杭州和正医药有限公司 The irreversible bruton's tyrosine kinase inhibitor of dibit point
CA2998796A1 (en) 2015-09-16 2017-03-23 Loxo Oncology, Inc. Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer
DK3390395T3 (en) 2015-12-16 2020-09-28 Loxo Oncology Inc Compounds that can be used as kinase inhibitors
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
MX2018007815A (en) * 2015-12-23 2019-07-04 Arqule Inc Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof.
CN106928231A (en) * 2015-12-31 2017-07-07 合肥中科普瑞昇生物医药科技有限公司 The kinase inhibitor of the new EGFR wild types of one class and saltant type
MX2018008653A (en) 2016-01-15 2018-12-10 Pfizer 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS.
CN108602834A (en) * 2016-02-05 2018-09-28 北京盛诺基医药科技有限公司 A kind of bruton's tyrosine kinase inhibitor
CN105777759B (en) * 2016-04-29 2018-01-26 杭州和正医药有限公司 A kind of bruton's tyrosine kinase inhibitor
WO2018002958A1 (en) 2016-06-30 2018-01-04 Sun Pharma Advanced Research Company Limited Novel hydrazide containing compounds as btk inhibitors
CN106146518A (en) * 2016-06-30 2016-11-23 苏州爱玛特生物科技有限公司 A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof
CA3043376A1 (en) * 2016-11-15 2018-05-24 Hangzhou Hertz Pharmaceutical Co., Ltd. Selective bruton's tyrosine kinase inhibitor and use thereof
CN109369654A (en) * 2018-11-20 2019-02-22 山东大学 1,3- bis- substituted-4-amino Pyrazolopyrimidines and its preparation method and application

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2526933B1 (en) 2006-09-22 2015-02-25 Pharmacyclics, Inc. Inhibitors of Bruton's tyrosine kinase
KR101425248B1 (en) 2007-03-28 2014-08-06 파마시클릭스, 인코포레이티드 Inhibitors of bruton's tyrosine kinase
WO2008054827A2 (en) 2006-11-03 2008-05-08 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
CA2986640C (en) 2008-06-27 2019-03-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
US8426428B2 (en) 2008-12-05 2013-04-23 Principia Biopharma, Inc. EGFR kinase knockdown via electrophilically enhanced inhibitors
US7718662B1 (en) 2009-10-12 2010-05-18 Pharmacyclics, Inc. Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
MX342405B (en) 2010-06-03 2016-09-28 Pharmacyclics Inc The use of inhibitors of bruton's tyrosine kinase (btk).
CA2836449A1 (en) 2011-05-17 2012-11-22 The Regents Of The University Of California Kinase inhibitors
KR102027598B1 (en) 2011-05-17 2019-10-01 프린시피아 바이오파마, 인코퍼레이티드 Tyrosine kinase inhibitors
US9138436B2 (en) 2011-07-13 2015-09-22 Pharmacyclics Llc Inhibitors of Bruton's tyrosine kinase
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Also Published As

Publication number Publication date
WO2014188173A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL249517A (en) Trk-inhibiting compound
HK1224312A1 (en) Novel compounds
HRP20171851T1 (en) Tetrahydropyrrolothiazine compounds
DK3354246T3 (en) Udstyrsmonteringssystem
AU354395S (en) Case
AU354443S (en) Case
HK1222846A1 (en) Substituted benzylpyrazoles
GB201413149D0 (en) No details
AU355447S (en) Case
GB201505425D0 (en) Not published
GB201311001D0 (en) Lucabella
HK1221717A1 (en) Substituted benzylpyrazoles
GB201307577D0 (en) New compounds
GB201311888D0 (en) Novel compounds
HK1222658A1 (en) Cyanotriazole compounds
PL2953956T3 (en) Heteropolyoxometalates
HK1219427A1 (en) Complex
GB201311910D0 (en) Novel Compounds
HRP20181775T1 (en) Arylquinazolines
GB201309085D0 (en) Compounds
GB201310542D0 (en) Compounds
GB201302927D0 (en) Compounds
EP2957205A4 (en) Hand-dryer
GB201317363D0 (en) Novel compounds
ZA201505682B (en) Microanchor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)